Experiment 68818
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Serenoa repens (ARECACEAE) |
| Citation | ROVEDA,S: COLOMBO,P:. (1994). CLINICAL CONTROLLED TRIAL ON THERAPEUTICAL BIOEQUIVALENCE AND TOLERABILITY OF SERENOA REPENS ORAL CAPSULES 160 MG OR RECTAL CAPSULES 640 MG.. 46() |
| Amount utilized | |
| Compound isolated | |
| Disease | AN OPEN, RANDOMIZED, CONTROLLED STUDY WAS PERFORMED IN 60 BENIGN PROSTATIC HYPERTROPHY PATIENTS. THEPATIENTS WERE RANDOMIZED INTO TWO GROUPS, THE 1ST (30 CASES) RECEIVING SERENOA REPENS ORAL CAPSULES (160 MG FOUR TIMES A DAY) FOR 30 DAYS AND 2ND (30 CASES) RECEIVING SERENOA REPENS RECTAL CAPSULES (640 MG ONCE A DAY) FOR 30 DAYS. CLINICAL EFFICACY WAS EVALUATED BY MEANS OF DIMINUTION OF SCORES ASSIGNED TO DYSURIA, POLLAKIURIA, PROSTATE DIMENSION AND MICTURATION RESIDUE. BOTH DOSES AND ROUTES OF ADMINISTRATION WERE EQUALLY EFFECTIVE. |
| Dose amount | 640.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | FIXED OIL |
| Gender | MALE |